Proteomics International has launched PromarkerEso at the ISDE World Congress in Brisbane (18–20 September). PromarkerEso is ...

The mathematical model is a computer simulation that shows how muscles in the throat and esophagus move when we swallow.

Investing.com -- ProPhase Labs Inc (NASDAQ:PRPH) stock surged 38% after the company announced it has secured a key patent for its biomarker-based system that assesses progression risk in Barrett’s ...

FULLERTON, Calif. (KABC) -- The latest findings reveal esophageal cancer rates are up across the board. Many factors can raise your risk, including your line of work. A recently FDA-approved, ...

Capsule sponge-based surveillance could be used in lieu of endoscopy for low-risk Barrett esophagus (BE) surveillance, a prospective multisite UK study found. The biomarker risk panel collected by the ...

Firefighters were at Providence St. Jude Medical Center in Fullerton on Wednesday, July 23, being screened with new technology designed to screen for a pre-cancerous condition known as Barrett’s ...

This year, more than 22,000 Americans face a chilling diagnosis — esophageal cancer. Men are three to four times more likely to develop it. The odds? Less than a 20% chance of surviving five years.

(WISH) — A new non-invasive test called EsoGuard offers hope for early detection of esophageal cancer, a disease affecting over 22,000 Americans each year. Esophageal cancer has a grim prognosis, with ...

Esophageal motility disorders occur more frequently among adults aged 75 years and older. Individuals aged 75 years and older have a higher prevalence of esophageal motility disorders, particularly ...

More than 22,000 Americans are diagnosed with esophageal cancer this year, with men being three to four times more likely to develop it. The survival rate beyond five years is less than 20%. What if ...

A new, non-invasive test called ESOGuard is giving patients a better chance at surviving one of the deadliest cancers in the country. More than 22,0000 Americans are expected to be diagnosed with ...